C4 Therapeutics, Inc.
CCCC
Revenue
7.24M
▲2.06M▲39.81%
3 Months ChangeAssets
319.52M
▼-30.08M▼-8.60%
3 Months ChangeLiabilities
124.38M
▼-9.23M▼-6.91%
3 Months ChangeFree Cash Flow
-18.12M
▲15.60M▲46.26%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044411
2024-10-31
Form 8-K
ID: 0001628280-24-044409
2024-10-15
Form 8-K
ID: 0001628280-24-042833
2024-10-11
Form 8-K
ID: 0001628280-24-042728
2024-09-03
Form 8-K
ID: 0001628280-24-039023
2024-08-01
Form 10-Q
ID: 0001628280-24-033882
2024-08-01
Form 8-K
ID: 0001628280-24-033874
2024-06-21
Form 8-K
ID: 0001628280-24-029301
2024-06-10
Form 8-K
ID: 0001628280-24-027399
2024-05-08
Form 10-Q
ID: 0001628280-24-021368